Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.83 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.83 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.83 |
| ▸ | MEN1 | O00255 | 1/20 | 0.83 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.83 |
| ▸ | MAPT | P10636 | 1/20 | 0.76 |
| ▸ | ENPP2 | Q13822 | 6/20 | 0.76 |
| ▸ | LPAR1 | Q92633 | 6/20 | 0.76 |
| ▸ | LPAR4 | Q99677 | 3/20 | 0.76 |
| ▸ | LPAR5 | Q9H1C0 | 3/20 | 0.76 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.76 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.76 |
| ▸ | LPAR6 | P43657 | 2/20 | 0.76 |
| ▸ | DGKA | P23743 | 2/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.68 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.65 |
| ▸ | CES2 | O00748 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7576639 | 1.00 | LMNA (0.83) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL9463924 | 1.00 | LMNA (0.83) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL9054375 | 1.00 | LMNA (0.83) | LMNAKDM4EDUSP3MEN1KMT2A | |
| 1,3-Dipalmitin SCHEMBL471830 | 1.00 | LMNA (0.83) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL9463581 | 1.00 | LMNA (0.83) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL21660226 | 1.00 | LMNA (0.83) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL11787098 | 1.00 | LMNA (0.83) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL9465207 | 1.00 | LMNA (0.83) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL17584914 | 1.00 | LMNA (0.83) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL17129723 | 1.00 | LMNA (0.83) | LMNAKDM4EDUSP3MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180064674-A1 | Compositions and Methods for the Treatment of Fatty Acid Metabolism Disorders | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 2018-03-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180064674-A1 | Compositions and Methods for the Treatment of Fatty Acid Metabolism Disorders | CPT1A, CPT1B, PC | LMNA 1231/4885KDM4E 3663/4885DUSP3 2808/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.